Franklin Biotechnology Discovery Fund Investor Sentiment

FTDZX Fund  USD 129.23  1.04  0.81%   
Slightly above 53% of Franklin Biotechnology's investor base is interested to short. The analysis of overall sentiment of trading Franklin Biotechnology Discovery mutual fund suggests that many investors are impartial at this time. Franklin Biotechnology's investing sentiment can be driven by a variety of factors including economic data, Franklin Biotechnology's earnings reports, geopolitical events, and overall market trends.
  
over a year ago at news.google.com         
Content is king Digital materials linked to 2.5 times boost to new ... - FiercePharma
Google News at Macroaxis
a minute ago at finance.yahoo.com         
Neurocrines Phase II schizophrenia trial fails to meet primary endpoint
Yahoo News
over a week ago at thelincolnianonline.com         
Wedbush Lifts Earnings Estimates for Neurocrine Biosciences
news
over a week ago at thefly.com         
Neurocrine price target raised by 5 at Barclays, heres why NBIX
news
over two weeks ago at finance.yahoo.com         
Neurocrine Biosciences Announces Commercial Availability of CRENESSITY for Children and Adults With ...
Yahoo News
over two weeks ago at medcitynews.com         
Neurocrine Lands FDA Nod for First New Treatment in Decades for Rare Endocrine Disorder
news
over two weeks ago at benzinga.com         
Neurocrines Drug Gains FDA Nod As First Targeted Treatment For Certain Type Of Inherited Disorder, A...
benzinga news
over two weeks ago at investors.com         
Neurocrine Wins FDA Approval For Genetic Disorder Drug
Investors Business Daily at Macroaxis
over two weeks ago at finance.yahoo.com         
Neurocrine Biosciences Announces FDA Approval of CRENESSITY , a First-in-Class Treatment for Childre...
Yahoo News
over three weeks ago at simplywall.st         
Shareholders Should Be Pleased With Neurocrine Biosciences, Inc.s Price
Simply Wall St News at Macroaxis
over three weeks ago at investing.com         
Spruce Biosciences SWOT analysis tildacerfont trials key for CAH stock
Investing News at Macroaxis
over a year ago at finance.yahoo.com         
Antibody Drug Conjugates Global Market Report 2023
Yahoo News
a day ago at thefly.com         
Vertex just downgraded at Raymond James, heres why VERX
news
2 days ago at finance.yahoo.com         
Paycor Stock Rises 45 percent in 6 Months Is There More Room to Run?
Yahoo News
3 days ago at zacks.com         
Vertex Pharmaceuticals Incorporated is Attracting Investor Attention Here is What You Should Know
zacks News
few days ago at bizjournals.com         
Vertex Energy files restructuring plan after filing for bankruptcy
bizjournals News
few days ago at zacks.com         
Vertex Pharmaceuticals Advances While Market Declines Some Information for Investors
zacks News
few days ago at gurufocus.com         
Vertex Pharmaceuticals Inc s Winning Formula Financial Metrics and Competitive Strengths
Gurufocus Stories at Macroaxis
few days ago at investing.com         
Vertex Energy progresses in bankruptcy, equity to be canceled
Investing News at Macroaxis
over a week ago at investors.com         
Dow Jones Futures Slide As Treasury Yields Climb Nvidia, Tesla Drop
Investors Business Daily at Macroaxis
over a week ago at fool.com         
Vertex Pharmaceuticals Stock Is Down 13. Heres Why You Should Buy the Dip
fool News
over a week ago at thelincolnianonline.com         
JPMorgan Chase Co. Issues Pessimistic Forecast for Vertex Pharmaceuticals Stock Price
news
over a year ago at reuters.com         
Pfizer forecasts 2024 profit, revenue below Wall Street expectations
reuters
over a year ago at seekingalpha.com         
Pfizer stock slips as 2024 guidance disappoints
seekingalpha News
over a year ago at cnbc.com         
Why investors should only trade a name like Linde on fundamentals
cnbc News
over a year ago at finance.yahoo.com         
Were Interested To See How Seagen Uses Its Cash Hoard To Grow
Yahoo News
over a year ago at businesswire.com         
ADCETRIS Plus Novel Immunotherapy Combination Delivers 100 percent Progression Free Survival at 12 m...
businesswire News
over a year ago at businesswire.com         
ADCETRIS Plus Novel Immunotherapy Combination Delivers 100 percent Progression Free Survival at 12 m...
businesswire News
over a year ago at dragonflycap.com         
5 Trade Ideas for MondayArista, Comerica, Interactive Brokers, Seagen and Teck Resources
news
over a year ago at benzinga.com         
100 Invested In Seagen 20 Years Ago Would Be Worth This Much Today
benzinga news
over a year ago at businesswire.com         
TUKYSA in Combination with Antibody-Drug Conjugate ado-Trastuzumab Emtansine Improves Progression-Fr...
businesswire News
over a year ago at thelincolnianonline.com         
Seagen Inc. Receives 193.00 Average PT from Analysts
news
over a year ago at www.macroaxis.com         
Disposition of 49701 shares by Michael Wortley of Reata Pharmaceuticals subject to Rule 16b-3
Macroaxis News
over a year ago at news.google.com         
Reata Pharmaceuticals, Inc. Is Expected To Breakeven In The Near Future - Yahoo Finance
Google News at Macroaxis
over a year ago at thelincolnianonline.com         
Reata Pharmaceuticals Research Coverage Started at StockNews.com
news
over a year ago at thelincolnianonline.com         
Reata Pharmaceuticals, Inc. Stock Holdings Trimmed by Swiss National Bank
news
over a year ago at thelincolnianonline.com         
StockNews.com Begins Coverage on Reata Pharmaceuticals
news
over a year ago at www.macroaxis.com         
Sale by Michael Wortley of 807 shares of Reata Pharmaceuticals
Macroaxis News
over a year ago at zacks.com         
Alimera Sciences Reports Q2 Loss, Lags Revenue Estimates
zacks News
over a year ago at zacks.com         
Entrada Therapeutics, Inc. Reports Q2 Loss, Misses Revenue Estimates
zacks News
over a year ago at Macroaxis         
Should you quit your Reata Pharmaceuticals (USA Stocks:RETA) holdings?
Macroaxis News
over a year ago at thelincolnianonline.com         
Reata Pharmaceuticals Cut to Neutral at LADENBURG THALMSH SH
news
a day ago at simplywall.st         
Regeneron Pharmaceuticals, Inc. Stock Has Shown Weakness Lately But Financials Look Strong Should Pr...
Simply Wall St News at Macroaxis
2 days ago at fool.com         
1 Beaten-Down Stock That Could Soar by 50 percent in 2025, According to Wall Street
fool News
3 days ago at insidermonkey.com         
Jim Cramers Take on Regeneron Pharmaceuticals Bold Predictions for the Future
insidermonkey News
few days ago at bizjournals.com         
Major projects teed up for Regeneron, Plug Power and GlobalFoundries
bizjournals News
over a week ago at kalkinemedia.com         
Age-related Macular Degeneration Treatment Market 2034 FDA Approvals, Drugs, Medication, and Compani...
news
over a week ago at benzinga.com         
If You Invested 100 In This Stock 15 Years Ago, You Would Have This Much Today
benzinga news
over two weeks ago at finance.yahoo.com         
Intellia Crashes 60 percent in a Year How Should You Play the Stock?
Yahoo News
over two weeks ago at finance.yahoo.com         
4 Biotech Stocks Most Wall Street Analysts Are Bullish About
Yahoo News
over two weeks ago at gurufocus.com         
Regeneron to Advance Two Factor XI Antibodies into a Broad Phase 3 Program Following Positive ...
Gurufocus Stories at Macroaxis
over two weeks ago at finance.yahoo.com         
Biotech Stock Roundup Updates From GILD, REGN, GSK, ANAB Down on Study Data, EWTX Gains
Yahoo News
few days ago at businesswire.com         
Disposition of 8279 shares by Klein Matthew B. of PTC Therapeutics at 45.16 subject to Rule 16b-3
businesswire News
over two weeks ago at kalkinemedia.com         
Why Are Insiders Rapidly Reducing Their Stake in PTC Therapeutics?
news
over two weeks ago at kalkinemedia.com         
Why Did PTC Therapeutics Stock Drop Midweek?
news
over two weeks ago at seekingalpha.com         
Morgan Stanley upgrades PTC, cuts Immuneering, Amicus
seekingalpha News
over three weeks ago at thelincolnianonline.com         
PTC Therapeutics Shares Gap Up Whats Next?
news
over three weeks ago at benzinga.com         
Novartis Touts Encouraging Data From Late-Stage Study For Fabhalta In Rare Type Of Blood Disorder
benzinga news
over three weeks ago at thelincolnianonline.com         
PTC Therapeutics, Inc. Director Sells 1,236,000.00 in Stock
news
over a month ago at investing.com         
Ptc Therapeutics chief technical officer sells shares worth 3.6 million
Investing News at Macroaxis
over a month ago at thelincolnianonline.com         
PTC Therapeutics Hits New 1-Year High on Analyst Upgrade
news
over a month ago at thelincolnianonline.com         
PTC Therapeutics Stock Price Expected to Rise, Robert W. Baird Analyst Says
news
22 hours ago at gurufocus.com         
Insider Sell James Young Sells 10,000 Shares of Novavax Inc
Gurufocus Stories at Macroaxis
2 days ago at newsweek.com         
COVID turns 5 facts and remaining mysteries about the virus
news
few days ago at thelincolnianonline.com         
Novavax Completes Sale of Biologics Manufacturing Campus in the Czech Republic Transaction Valued at...
news
over a week ago at finance.yahoo.com         
Novavax, Inc. Is a Trending Stock Facts to Know Before Betting on It
Yahoo News
over a week ago at talkmarkets.com         
Are You Ready To Trade Biotech Stocks At The Cusp Of A Bear Market?
news
over two weeks ago at thelincolnianonline.com         
Novavax Enters Amendment to Advanced Purchase Agreement with Commonwealth of Australia
news
over two weeks ago at finance.yahoo.com         
The specter of RFK Jr. has investors fretting about a onetime vaccine wunderkind
Yahoo News
over two weeks ago at gurufocus.com         
Novavax Inc Achieves Key Milestone in Sanofi Partnership
Gurufocus Stories at Macroaxis
over three weeks ago at thelincolnianonline.com         
Neo Ivy Capital Management Takes Position in Novavax, Inc.
news
over three weeks ago at zacks.com         
Why Is Novavax Up 13.6 percent Since Last Earnings Report?
zacks News
over six months ago at thelincolnianonline.com         
Mirati Therapeutics Now Covered by Analysts at StockNews.com
news
over six months ago at finance.yahoo.com         
Billionaire Joe Lewis Pleads Guilty in Insider Trading Case
Yahoo News
over six months ago at smh.com.au         
Billionaire pleads guilty in insider trading case with a link to an Australian giant
news
over six months ago at streetinsider.com         
Frances Sanofi to buy U.S. drugs project INBRX-101 for about 2.2 billion
Street Insider News
over six months ago at streetinsider.com         
Frances Sanofi to buy U.S. drugs project INBRX-101 for about 2.2 billion
Street Insider News
over six months ago at streetinsider.com         
Frances Sanofi to buy U.S. drugs project INBRX-101 for about 2.2 billion
Street Insider News
over six months ago at streetinsider.com         
Frances Sanofi to buy U.S. drugs project INBRX-101 for about 2.2 billion
Street Insider News
over six months ago at aol.com         
Frances Sanofi to buy U.S. drugs project INBRX-101 for about 2.2 billion
news
over six months ago at seekingalpha.com         
Mirati Therapeutics stock ticks higher amid Nasdaq delisting for sale to Bristol-Myers
seekingalpha News
over six months ago at thelincolnianonline.com         
Brokerages Set Mirati Therapeutics, Inc. PT at 60.00
news
a minute ago at accesswire.com         
Class Action Filed Against Moderna, Inc. Seeking Recovery for Investors - Contact Levi Korsinsky
news
a day ago at www.macroaxis.com         
Disposition of 4279 shares by Noubar Afeyan of Moderna at 117.1812 subject to Rule 16b-3
Macroaxis News
2 days ago at thewest.com.au         
Rita Saffioti 10 things Ocean Reef Marina to become an iconic precinct
news
few days ago at channelnewsasia.com         
Police reopen 6 areas around Marina Bay after closure due to large crowds at New Year countdown
news
few days ago at nytimes.com         
Jimmy Carter y su legado en la Marina de EE. UU. un submarino espa ultrasecreto lleva su nombre
nitimes news
over a week ago at fool.com         
Meet the Newest Stock in the Nasdaq-100. Its Soared 110,600 percent Since Its IPO and Its Still a Bu...
fool News
over a week ago at news.mit.edu         
MIT community in 2024 A year in review
news
over a week ago at forbes.com         
Inside Look Marina Bay Sands Review
Usa forbes News
over a week ago at apnews.com         
Derriban a 2 pilotos de Marina sobre el Mar Rojo en aparente incidente de fuego amigo
Macroaxis News: apnews.com
over two weeks ago at kalkinemedia.com         
IGY Marina Cabo San Lucas contina fortaleciendo sus vnculos con la comunidad a travs de iniciativas ...
news
a minute ago at simplywall.st         
Jazz Pharmaceuticals investors are sitting on a loss of 20 percent if they invested a year ago
Simply Wall St News at Macroaxis
over a week ago at finance.yahoo.com         
Debbies Dream Foundation Curing Stomach Cancer Celebrates a Year of Impactful Programs and Community...
Yahoo News
over two weeks ago at investing.com         
Akari Therapeutics appoints new CEO and board member
Investing News at Macroaxis
over two weeks ago at finance.yahoo.com         
Jazz Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Yahoo News
over two weeks ago at gurufocus.com         
Jazz Pharmaceuticals Announces CEO Succession Plan
Gurufocus Stories at Macroaxis
over two weeks ago at finance.yahoo.com         
Is Now The Time To Put Jazz Pharmaceuticals On Your Watchlist?
Yahoo News
over three weeks ago at finance.yahoo.com         
Zymeworks Hosts RD Day Highlighting Continued Clinical Progress in Oncology Programs and Expansion i...
Yahoo News
over three weeks ago at zacks.com         
5 High ROE Stocks to Buy as Volatility Weighs on Markets
zacks News
over three weeks ago at benzinga.com         
CBD Drug For Tuberous Sclerosis Caregivers Continue Epidiolex Treatment Citing Seizure Reduction And...
benzinga news
over three weeks ago at zacks.com         
Jazz Up 3.4 percent Since Last Earnings Report Can It Continue?
zacks News
a day ago at finance.yahoo.com         
Why Iovance Biotherapeutics Stock Zoomed More Than 5 percent Higher Today
Yahoo News
2 days ago at thelincolnianonline.com         
Iovance Biotherapeutics Shares Up 7.7 percent Heres What Happened
news
over two weeks ago at gurufocus.com         
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635
Gurufocus Stories at Macroaxis
over two weeks ago at fool.com         
If I Could Only Buy 3 Stocks in the Last Month of 2024, Id Pick These
fool News
over two weeks ago at fool.com         
2 Growth Stocks That Could Rocket Higher in 2025 Are They Right for Your Portfolio?
fool News
over three weeks ago at fool.com         
Prediction This Stock Will Beat the Market in 2025
fool News
over three weeks ago at thelincolnianonline.com         
Iovance Biotherapeutics, Inc. Receives Consensus Recommendation of Moderate Buy from Brokerages
news
over a month ago at news.google.com         
IOVA - Iovance Biotherapeutics, Inc. Latest Stock News Market Updates - StockTitan
Google News at Macroaxis
over a month ago at gurufocus.com         
Iovance Biotherapeutics Announces the Promotion of Raj Puri, M.D., Ph.D. to Chief Regulatory Officer
Gurufocus Stories at Macroaxis
over a month ago at finance.yahoo.com         
Insider Trading
Yahoo News
over a year ago at news.google.com         
Form 485BPOS INSTITUTIONAL FIDUCIARY - StreetInsider.com
Google News at Macroaxis
22 hours ago at gurufocus.com         
Illumina Inc Shares Up 3.88 percent on Jan 4
Gurufocus Stories at Macroaxis
2 days ago at finance.yahoo.com         
Microfluidics Global Market Research 2024-2029 Organ-on-a-Chip Innovations Propel the 32 Billion Ind...
Yahoo News
few days ago at investors.com         
IBD Rating Upgrades Illumina Shows Improved Technical Strength
Investors Business Daily at Macroaxis
over a week ago at finance.yahoo.com         
Metagenomic Market Research 2025-2029 - Global Market Analysis and Forecasts with Executive and Cons...
Yahoo News
over a week ago at livebitcoinnews.com         
Brian Brooks Joins MicroStrategy Board After Binance.US Exit
news
over two weeks ago at bnnbloomberg.ca         
Nvidias Deal to Buy Israels Runai Wins Unconditional EU Nod
bloomberg News
over two weeks ago at insidermonkey.com         
Illumina, Inc. Sees Modest Gains Amid Regulatory Approvals and Market Speculation
insidermonkey News
over two weeks ago at gurufocus.com         
Illumina Inc Showcases Employee Impact on Global Health
Gurufocus Stories at Macroaxis
over two weeks ago at finance.yahoo.com         
Is There Now An Opportunity In Illumina, Inc.?
Yahoo News
over two weeks ago at finance.yahoo.com         
Stock market today SP 500 rises, Nasdaq hovers near fresh record as countdown to Fed decision begins
Yahoo News
over a year ago at www.macroaxis.com         
Disposition of 110447 shares by Thomas Watkins of Horizon Pharma subject to Rule 16b-3
Macroaxis News
over a year ago at news.google.com         
Institutional owners may consider drastic measures as Vir Biotechnology, Inc.s recent US85m drop add...
Google News at Macroaxis
over a year ago at businesswire.com         
Horizon Therapeutics plc Rule 2.12 Announcement
businesswire News
over a year ago at benzinga.com         
Heres How Much 1000 Invested In Horizon Therapeutics 10 Years Ago Would Be Worth Today
benzinga news
over a year ago at news.google.com         
U.S. FTC allows Amgen to move forward with 27.8 bln Horizon deal - CNBC - Marketscreener.com
Google News at Macroaxis
over a year ago at thelincolnianonline.com         
Toronto Dominion Bank Buys 185,145 Shares of Horizon Therapeutics Public Limited
news
over a year ago at finance.yahoo.com         
Horizon Up as FTC Pauses Acquisition by Amgen Lawsuit
Yahoo News
over a year ago at finance.yahoo.com         
Horizon Therapeutics plc Ranks First in Overall Corporate Reputation by Rare Disease Patient Advocac...
Yahoo News
over a year ago at marketwatch.com         
George Soros has a big stake in this stock but its posted a roughly 9 percent loss this year. Are th...
marketwatch News
over a year ago at thelincolnianonline.com         
Horizon Therapeutics Public Issues Earnings Results
news
a day ago at finance.yahoo.com         
Gilead Sciences Stock Declines While Market Improves Some Information for Investors
Yahoo News
2 days ago at cnbc.com         
Insider Trading
cnbc News
few days ago at newsweek.com         
The biggest reason to be optimistic about 2025, according to philosophers
news
few days ago at deseret.com         
Pivotal step University of Utah biochemists HIV research contributes to Sciences Breakthrough of the...
news
few days ago at investing.com         
Legend Biotechs SWOT analysis carvyktis promise drives stock outlook
Investing News at Macroaxis
few days ago at theatlantic.com         
The Most Important Breakthroughs of 2024
news
over a week ago at finance.yahoo.com         
Gilead Sciences, Inc. is Attracting Investor Attention Here is What You Should Know
Yahoo News
over a week ago at seekingalpha.com         
Assembly Bio stock spikes on Gilead-partnered drug
seekingalpha News
over a week ago at investors.com         
Nvidia Stock Is At Its 50-Day Line. This Trade Gets You Bullish Exposure With Limited Risk.
Investors Business Daily at Macroaxis
over a week ago at investors.com         
Gilead Sciences Stock Today Boost Your Return With This Covered Call Trade
Investors Business Daily at Macroaxis
over six months ago at seekingalpha.com         
Ono Pharmaceutical completes tender offer for Deciphera
seekingalpha News
over six months ago at finance.yahoo.com         
Deciphera Pharmaceuticals Announces Oral Presentation of Results from MOTION Pivotal Phase 3 Study o...
Yahoo News
over six months ago at news.google.com         
Charles Schwab Investment Management Inc. Has 8.31 Million Position in Deciphera Pharmaceuticals, In...
Google News at Macroaxis
over six months ago at news.google.com         
Decipheras Shares Surge 74.3 percent in a Month Heres Why - Zacks Investment Research
Google News at Macroaxis
over six months ago at zacks.com         
Heres What Key Metrics Tell Us About Deciphera Pharmaceuticals Q1 Earnings
zacks News
over six months ago at news.google.com         
Deciphera Pharmaceuticals Investment Analysts Weekly Ratings Changes - Defense World
Google News at Macroaxis
over six months ago at finance.yahoo.com         
Biotech Stock Roundup GILDs GSK Q1 Earnings, DCPH Soars on Acquisition News More
Yahoo News
over six months ago at benzinga.com         
SHAREHOLDER INVESTIGATION Halper Sadeh LLC Investigates HRT, DCPH, UMBF
benzinga news
over six months ago at seekingalpha.com         
ONO to acquire Deciphera Pharmaceuticals in 2.4B deal
seekingalpha News
over six months ago at businesswire.com         
Deciphera Pharmaceuticals to be Acquired by ONO Pharmaceutical For 2.4 Billion
businesswire News
2 days ago at finance.yahoo.com         
3 Reasons Why Growth Investors Shouldnt Overlook BioMarin
Yahoo News
few days ago at finance.yahoo.com         
Sangamo Plunges After Pfizer Ends Pact for Hemophilia Drug
Yahoo News
few days ago at finance.yahoo.com         
Rocket Pharmaceuticals, Inc. Is This Gene Therapy Stock a Good Buy Right Now?
Yahoo News
over a week ago at simplywall.st         
Does BioMarin Pharmaceutical Have A Healthy Balance Sheet?
Simply Wall St News at Macroaxis
over two weeks ago at finance.yahoo.com         
Is the Options Market Predicting a Spike in BioMarin Pharmaceutical Stock?
Yahoo News
over two weeks ago at finance.yahoo.com         
Press Registration Is Now Open for the 2025 ACMG Annual Clinical Genetics Meeting
Yahoo News
over two weeks ago at investing.com         
BridgeBios SWOT analysis genetic disease specialists stock poised for growth
Investing News at Macroaxis
over three weeks ago at finance.yahoo.com         
Are BioMarin Pharmaceutical Inc.s Mixed Financials The Reason For Its Gloomy Performance on The Stoc...
Yahoo News
over three weeks ago at finance.yahoo.com         
Are You a Value Investor This 1 Stock Could Be the Perfect Pick
Yahoo News
over three weeks ago at finance.yahoo.com         
Are You a Growth Investor This 1 Stock Could Be the Perfect Pick
Yahoo News
a minute ago at kalkinemedia.com         
Japan gives priority review status to Alzheimers drug developed by Eisai, Biogen
news
2 days ago at thefly.com         
Biogen just downgraded at Piper Sandler, heres why BIIB
news
3 days ago at finance.yahoo.com         
Why Biogen Inc. is a Top Value Stock for the Long-Term
Yahoo News
few days ago at businesswire.com         
Cancer Immunotherapy Market Research 2025-2029 Forecasts for Immuno-Oncology Therapeutics by Therapy...
businesswire News
six days ago at finance.yahoo.com         
Biogen Inc. Among the Cheap Healthcare Stocks to Buy Heading Into 2025
Yahoo News
over a week ago at kalkinemedia.com         
Why Is Biogen Struggling to Maintain Stability in the Market?
news
over a week ago at finance.yahoo.com         
Biogen Faces Multiple Analyst Downgrades in December 2024
Yahoo News
over two weeks ago at thefly.com         
Biogen just downgraded at BMO Capital, heres why BIIB
news
over two weeks ago at finance.yahoo.com         
Regenerative Medicine Research Report 2024-2031 Approvals for New Regenerative Medicines and Increas...
Yahoo News
over two weeks ago at investing.com         
Biogens SWOT analysis stock outlook amid alzheimers drug launch and pipeline shifts
Investing News at Macroaxis
over a week ago at zacks.com         
Sage Therapeutics Surges 12.2 percent Is This an Indication of Further Gains?
zacks News
over two weeks ago at globenewswire.com         
YORVIPATH Now Commercially Available in the United States for the Treatment of Hypoparathyroidism in...
Macroaxis News: globenewswire.com
over two weeks ago at investing.com         
BioMarins SWOT analysis rare disease leaders stock faces growth hurdles
Investing News at Macroaxis
over two weeks ago at finance.yahoo.com         
New InsiGHTS Trial of TransCon hGH in Turner Syndrome Achieved Primary Objective at Week 26
Yahoo News
over three weeks ago at finance.yahoo.com         
FDA Accepts Ascendis Pharmas Supplemental Biologics License Application for TransCon hGH for the Tre...
Yahoo News
over three weeks ago at finance.yahoo.com         
Er-Kim Extends Exclusive Distribution Agreement with Ascendis Pharma AS to Expand Commercialization ...
Yahoo News
over three weeks ago at thelincolnianonline.com         
RA Capital Management L.P. Has 1.45 Billion Stake in Ascendis Pharma AS
news
over a month ago at thelincolnianonline.com         
Brokerages Set Ascendis Pharma AS Target Price at 191.77
news
over a month ago at investing.com         
Ascendis Pharmas SWOT analysis stock faces growth hurdles amid pipeline promise
Investing News at Macroaxis
over a month ago at thelincolnianonline.com         
Ascendis Pharma AS Price Target Raised to 207.00
news
few days ago at finance.yahoo.com         
Why Array Technologies Is Among the Best Renewable Energy Stocks to Buy?
Yahoo News
over two weeks ago at businesswire.com         
Colorados Life Sciences Ecosystem Raised 2.15 Billion in 2024
businesswire News
over two weeks ago at www.macroaxis.com         
Acquisition by Neil Manning of 5700 shares of Array Technologies at 5.21 subject to Rule 16b-3
Macroaxis News
over three weeks ago at news.google.com         
Array Technologies stock hits 52-week low at 5.51 - Investing.com
Google News at Macroaxis
over a month ago at gurufocus.com         
ARRAY Technologies and RP Surpass 6GW of Solar Power Deployed
Gurufocus Stories at Macroaxis
over a month ago at bizjournals.com         
Abq solar firm Arrays 3M investment lets robots do what they do best
bizjournals News
over a month ago at investing.com         
Array Technologies CEO Kevin Hostetler acquires 100,037 in stock
Investing News at Macroaxis
over a month ago at gurufocus.com         
ARRAY Announces 3 Million Investment in Swap Robotics to Drive Automation in PV Installation
Gurufocus Stories at Macroaxis
over a month ago at gurufocus.com         
Hill City Capital, LP Increases Stake in Array Technologies Inc
Gurufocus Stories at Macroaxis
over a month ago at insidermonkey.com         
Array Technologies, Inc. Q3 2024 Earnings Call Transcript
insidermonkey News
a day ago at benzinga.com         
Heres How Much You Would Have Made Owning argenx Stock In The Last 5 Years
benzinga news
over a week ago at zacks.com         
Is Alnylam Pharmaceuticals Stock Outpacing Its Medical Peers This Year?
zacks News
over two weeks ago at benzinga.com         
Biohaven Advances in Immunotherapy Significant IgG Reduction Achieved with BHV-1300, Gains Analyst A...
benzinga news
over three weeks ago at finance.yahoo.com         
Heres Why argenx SE Surged in Q3
Yahoo News
over three weeks ago at zacks.com         
Is Butterfly Network Stock Outpacing Its Medical Peers This Year?
zacks News
over a month ago at thelincolnianonline.com         
Polymer Capital Management HK LTD Has 3.58 Million Stake in argenx SE
news
over a month ago at thelincolnianonline.com         
Cynosure Group LLC Sells 499 Shares of argenx SE
news
over a month ago at investing.com         
Can Argenx stock sustain its autoimmune category dominance Oppenheimer weighs in
Investing News at Macroaxis
over a month ago at finance.yahoo.com         
Is argenx SE the Best Immunotherapy Stock to Buy Now?
Yahoo News
over a month ago at gurufocus.com         
Paradigm Biocapital Advisors LP Increases Stake in Tarsus Pharmaceuticals Inc
Gurufocus Stories at Macroaxis
22 hours ago at finance.yahoo.com         
Prediction These 3 Healthcare Stocks Will Soar in 2025
Yahoo News
2 days ago at finance.yahoo.com         
1 Beaten-Down Stock That Could Soar by 50 percent in 2025, According to Wall Street
Yahoo News
3 days ago at finance.yahoo.com         
Is the Schwab U.S. Dividend Equity ETF a Millionaire Maker?
Yahoo News
few days ago at zacks.com         
Amgen Advances While Market Declines Some Information for Investors
zacks News
few days ago at insidermonkey.com         
Is Amgen Inc. the Best Pharma Dividend Stock to Buy In 2024?
insidermonkey News
few days ago at zacks.com         
Amgen Suffers a Larger Drop Than the General Market Key Insights
zacks News
over a week ago at zacks.com         
Are You a Value Investor This 1 Stock Could Be the Perfect Pick
zacks News
over a week ago at bizjournals.com         
Amgen buys 22 acres near its New Albany facility
bizjournals News
over a week ago at finance.yahoo.com         
3 Top-Ranked Dividend Stocks A Smarter Way to Boost Your Retirement Income
Yahoo News
over a week ago at zacks.com         
Investors Heavily Search Amgen Inc. Here is What You Need to Know
zacks News
a day ago at kalkinemedia.com         
Innovent Announces Second New Drug Application of DOVBLERON was Approved by Chinas National Medical ...
news
few days ago at www.macroaxis.com         
Acquisition by Harrigan Edmund of 3 shares of Incyte at 69.07 subject to Rule 16b-3
Macroaxis News
over a week ago at zacks.com         
EXEL vs. INCY Which Stock Should Value Investors Buy Now?
zacks News
over a week ago at thelincolnianonline.com         
Acquisition by Herve Hoppenot of 41577 shares of Incyte subject to Rule 16b-3
news
over two weeks ago at kalkinemedia.com         
Innovent Receives Approval of DOVBLERON by Chinas National Medical Products Administration
news
over two weeks ago at finance.yahoo.com         
Myeloproliferative Disorders Drugs Market Forecast to 2030 JAK Inhibitors, Combination Therapies, an...
Yahoo News
over two weeks ago at investing.com         
Incytes SWOT analysis stock faces patent cliff as pipeline progress unfolds
Investing News at Macroaxis
over two weeks ago at thelincolnianonline.com         
Disposition of 650 shares by Thomas Tray of Incyte at 70.64 subject to Rule 16b-3
news
over three weeks ago at businesswire.com         
Aktuelle Incyte Tafasitamab Daten demonstrieren auf dem ASH 2024 deutlich verbessertes progressionsf...
businesswire News
over three weeks ago at businesswire.com         
Samenvatting Laat-brekende Incyte-gegevens van Tafasitamab op ASH 2024 tonen significant verbeterde ...
businesswire News
over a year ago at finance.yahoo.com         
Orphan Drug Market Size Share to Surpass 3199.3 Billion by 2028 Vantage Market Research
Yahoo News
a day ago at kalkinemedia.com         
Why Is Heron Therapeutics Struggling to Regain Its Momentum?
news
over a week ago at finance.yahoo.com         
1 Top Quantum Computing Stock to Buy Right Now
Yahoo News
over two weeks ago at ndtv.com         
Brazil Heron Flies After Rescuers Remove Plastic Cup From Its Throat
news
over a month ago at aol.com         
School pilot scheme to assess neurodivergent needs
news
over a month ago at bbc.co.uk         
Heron Foods Grimsby store must have security to sell alcohol
news
over a month ago at thelincolnianonline.com         
Heron Therapeutics Posts Earnings Results, Meets Expectations
news
over a month ago at gurufocus.com         
Heron Therapeutics Inc Q3 2024 Earnings Call Highlights Strategic Initiatives Drive ...
Gurufocus Stories at Macroaxis
over a month ago at insidermonkey.com         
Heron Therapeutics, Inc. Q3 2024 Earnings Call Transcript
insidermonkey News
over a month ago at zacks.com         
Heron Therapeutics Q3 Earnings How Key Metrics Compare to Wall Street Estimates
zacks News
over a month ago at seekingalpha.com         
Heron Therapeutics Q3 2024 Earnings Preview
seekingalpha News
Far too much social signal, news, headlines, and media speculation about Franklin Biotechnology that are available to investors today. That information is available publicly through Franklin media outlets and privately through word of mouth or via Franklin internal channels. However, regardless of the origin, that massive amount of Franklin data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Franklin Biotechnology news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Franklin Biotechnology relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Franklin Biotechnology's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Franklin Biotechnology alpha.

Franklin Biotechnology Minimum Initial Investment

Based on the recorded statements, Franklin Biotechnology Discovery has a Minimum Initial Investment of 100 K. This is 65.56% higher than that of the Franklin Templeton Investments family and significantly higher than that of the Health category. The minimum initial investment for all United States funds is notably lower than that of the firm.
Fund managers put minimum investment restrictions on fund investments in order to allow the fund to function properly. Minimum restrictions allow fund managers to regulate cash flows of the fund, while guarding it against random trades that may negatively affect fund strategy.

Other Information on Investing in Franklin Mutual Fund

Franklin Biotechnology financial ratios help investors to determine whether Franklin Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Franklin with respect to the benefits of owning Franklin Biotechnology security.
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm